Mohammad Keyvanloo Shahrestanaki & Mahmoud Aghaei. (2019). A3 receptor agonist, Cl-IBMECA, potentiate glucose-induced insulin secretion from MIN6 insulinoma cells possibly through transient Ca2+ entry. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationMohammad Keyvanloo Shahrestanaki and Mahmoud Aghaei. A3 Receptor Agonist, Cl-IBMECA, Potentiate Glucose-induced Insulin Secretion from MIN6 Insulinoma Cells Possibly Through Transient Ca2+ Entry. Wolters Kluwer Medknow Publications, 2019.
MLA (9th ed.) CitationMohammad Keyvanloo Shahrestanaki and Mahmoud Aghaei. A3 Receptor Agonist, Cl-IBMECA, Potentiate Glucose-induced Insulin Secretion from MIN6 Insulinoma Cells Possibly Through Transient Ca2+ Entry. Wolters Kluwer Medknow Publications, 2019.
Warning: These citations may not always be 100% accurate.